The Clinical Trials Guru

Links shared publicly online about this topic.

  • 1,361
    total visits

The Clinical Trials Guru

theclinicaltrialsguru.com

The Clinical Trials Guru

View full resource at theclinicaltrialsguru.com

Tags: Clinical Trial

  • Share

Most Recently Shared on July 9, 2010 at 8:27 pm By:

MiriamETucker Miriam E. Tucker

RT @TheRealDanSfera: Debunking some common clinical trials myths and misconceptions http://ping.fm/OQR0U

2 years ago...

Also Shared By:

Phil Baumann Phil Baumann

Attending an FDA Hearing for Pfizer’s JAK: Tofacitinib CP-690550 | RA Education | Rheumatoid Arthritis Warrior

rawarrior.com — “Three years ago, one of the first friends I made through my blog was Angie. She got into a Pfizer clinical trial for tofacitinib (then called tasocitinib). She...View full resource at rawarrior.com

  • View Related
  • Share

Most Recently Shared on May 6, 2012 at 9:00 am By:

Kelly_Young Kelly Young ePatient

New Post: Attending an FDA Hearing for Pfizer’s JAK: Tofacitinib CP-690550 http://t.co/s71kIumW #rheum

4 days ago...

Treating Patients Enrolled in Clinical Trials

onclive.com — “All oncology nurses—not just nurse researchers—will need to understand the fundamentals of clinical trials as patient access to the studies continues to expand.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on May 5, 2012 at 5:29 pm By:

ONClive Editor Oncology

Treating Patients Enrolled in Clinical Trials http://t.co/td7Evcaa #ONScongress

5 days ago...

EHR alerts help recruit patients for clinical trials - FierceEMR

fierceemr.com — “Clinical trial alerts (CTAs) generated by electronic health records are subject to alert fatigue, but remain helpful in potential recruitment of participants in clinical trials, according to a new Read more...View full resource at fierceemr.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 3:32 pm By:

Guidelines on cardiovascular disease prevention in clinical practice launched at EuroPRevent2012

news-medical.net — “The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies. The "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)" - were launched at the EuroPRevent2012 meeting in Dublin, Ireland.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 2:44 pm By:

NewsMedical News-Medical.Net Health News

Guidelines on cardiovascular disease prevention in clinical practice launched at EuroPRevent2012: The latest car... http://t.co/MX1TECEW

6 days ago...

A Bill To Require Clinical Trial Disclosures // Pharmalot

pharmalot.com — “A Bill To Require Clinical Trial Disclosures // PharmalotView full resource at pharmalot.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 1:59 pm By:

pharmalot pharmalot

A Bill Is Introduced to Require Clinical Trials Regardless of Outcomes... read it here http://t.co/VQGzZGmR #pharma

6 days ago...

AIDSmeds - Top Stories : Gene-Modified T Cells Persist for a Decade, Without Major Risks, in HIV Studies - by Tim Horn

aidsmeds.com — “Genetically modified T cells--notably CD4 and CD8 cells--administered to people living with HIV participating in one of three clinical trials conducted between 1998 and 2002 are detectable more than a decade later, suggesting that single infusions of cells altered to target or block HIV have the potential for long-term efficacy. According to the paper, published in the May 2 issue of Science Translational Medicine and summarized in a University of Pennsylvania news release, the long-term safety View full resource at aidsmeds.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 12:54 pm By:

AIDSmeds AIDSmeds Health News

Top Stories : Gene-Modified T Cells Persist for a Decade, Without Major Risks, in #HIV Studies http://t.co/CxlMuGLC #AIDS

6 days ago...

Bionic eye helps two blind men see for the first time in 20 years

news-medical.net — “In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a “bionic eye”. Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and “exceeded expectations”.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 11:25 am By:

NewsMedical News-Medical.Net Health News

Bionic eye helps two blind men see for the first time in 20 years: In a medical breakthrough two blind men have ... http://t.co/1wvYbNTm

6 days ago...

Cell Therapy Shows Promise In Fight Against HIV

medicalnewstoday.com — “UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS.In a papeView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 7:05 am By:

Randomized Clinical Trials: Et Tu, Subgroup? : Cardiology News

ecardiologynews.com — “Cardiology News is an independent news source that provides cardiologists with timely and relevant news and commentary about clinical developments and the impact of health care policy on cardiology and the cardiologist's practice. Cardiology News Digital Network is the online destination and multimedia properties of Cardiology News, the independent news publication for cardiologists. Cardiology news is the leading source of news and commentary about clinical developments in cardiology as well asView full resource at ecardiologynews.com

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 8:15 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

Blog: Dr. Paul Hauptman reflects on the contradictions inherent in the randomized clinical trial setup: http://t.co/JkzYxITX

1 week ago...

Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases

hindawi.com — “Cardiovascular diseases are one of the major causes of deaths in adults in the western world. Elevated levels of certain blood lipids have been reported to be the principal cause of cardiovascular disease and other disabilities in developed countries. Several animal and clinical trials have shown a positive association between cholesterol levels and the risks of coronary heart disease. Current dietary strategies for the prevention of cardiovascular disease advocate adherence to low-fat/low-saturView full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 6:29 pm By:

Cholesterol_OW Cholesterol OW OW Health

Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases: Cardiovascular diseases are... http://t.co/WvFFZulO

1 week ago...

Geron Completes Enrollment in Phase 2 Clinical Trial of Imetelstat in Non-Small Cell Lung Cancer - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: MENLO PARK, Calif., May 3, 2012 - Geron Corporation (GERN) today announced that the company has completed planned enrollment of its randomized Phase 2 clinical trial of imetelstat, a telomerase ...View full resource at finance.yahoo.com

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 12:30 pm By:

LungCancer Lung Cancer OW OW Health

Geron Completes Enrollment in Phase 2 Clinical Trial of Imetelstat in Non-Small Cell Lung Cancer: MENLO PARK, Ca... http://t.co/MyaNez9V

1 week ago...

EarlyCDT®-Lung to be Part of a Randomized Clinical Trial of Patients at High Risk for Lung Cancer, Conducted by the Scottish Government - Yahoo! News

news.yahoo.com — “From Yahoo! News: Oncimmune® (USA) LLC, developer of EarlyCDT®-Lung, a commercially available blood test designed to aid in the early detection of lung cancer in high risk individuals, announces that EarlyCDT-Lung will be part of a large clinical trial to be conducted by the Scottish Government.De Soto, Kans. (PRWEB) May 03, 2012 Oncimmune® (USA) LLC, creator of EarlyCDT®-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, announces that EarlView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 6:28 am By:

LungCancer Lung Cancer OW OW Health

EarlyCDT®-Lung to be Part of a Randomized Clinical Trial of Patients at High Risk for Lung Cancer, Conducted by ... http://t.co/aN76iKWD

1 week ago...

Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro for Treatment of Chronic Pain

drugs.com — “Zohydro (hydrocodone) is a new drug formulation in development for the treatment of chronic pain. Zohydro information includes news, clinical trial results and side effects.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 2:05 am By:

drugscom Drugs.com Health Site

Zogenix Submits NDA to FDA for Zohydro (hydrocodone extended-release capsules) for Chronic Pain - http://t.co/0mRPUjz4

1 week ago...

Interpreting The Avastin-Lucentis Study For Persons With Macular Degeneration

medicalnewstoday.com — “This week, the second-year results of an important clinical trial on age-related macular degeneration (AMD), known as the Comparison of AMD Treatments Trials (or CATT), were published in the journView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 12:05 pm By:

mnt_seniors MNT Seniors News Health News

Interpreting The Avastin-Lucentis Study For Persons With Macular Degeneration http://t.co/mzwSJos0 #seniors

1 week ago...

Large-scale analysis finds majority of clinical trials don't provide meaningful evidence

sciencedaily.com — “The largest comprehensive analysis of ClinicalTrials.gov finds that clinical trials are falling short of producing high-quality evidence needed to guide medical decision-making. The analysis found the majority of clinical trials is small, and there are significant differences among methodical approaches, including randomizing, blinding and the use of data monitoring committees.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 11:27 am By:

Advertisement